Sign In
Buy LLY
$1,131.42
+6.15 (+0.547%)
At Close: Jun 05, 2026
Three Biotech Stocks to Buy for the "Golden Age of Medicine"
01:49pm, Monday, 19'th Aug 2024
A year ago, medical experts and Nobel Laureates interviewed by The New York Times proclaimed "a Golden Age of Medicine" is here.
Prediction: These 2 Unstoppable Pharma Stocks Will Continue to Soar Through 2025 and Beyond
05:11am, Monday, 19'th Aug 2024
Novo Nordisk and Eli Lilly won't be constrained by manufacturing too much longer. That means they'll sell more of their in-demand drugs.
2 Goldman Sach stocks to turn $100 to $1000 by 2025
04:22am, Monday, 19'th Aug 2024
Banking giant Goldman Sachs (NYSE: GS) has identified several stocks likely to witness an upside in the future based on their key fundamentals.
Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived
02:10pm, Sunday, 18'th Aug 2024
Last November, Eli Lilly received FDA approval for obesity drug Zepbound. In the second quarter, Zepbound generated over $1.2 billion in revenue!
Prediction: This Hypergrowth Company Could Be the Next Trillion-Dollar Stock
12:05pm, Sunday, 18'th Aug 2024
Eli Lilly is one of a few corporations close to hitting the $1 trillion mark. Despite a rich-looking valuation, the company should continue delivering strong returns.
Our Top 10 Dividend Growth Stocks - August 2024
09:00am, Sunday, 18'th Aug 2024
This article focuses on selecting high-growth dividend stocks with rapidly growing dividends rather than high current yields. We use our proprietary models to rate quantitatively and qualitatively and
Novo Nordisk and Eli Lilly Could Have a Big Rival in the GLP-1 Market in a Few Years
06:12am, Sunday, 18'th Aug 2024
The anti-obesity market is a huge growth opportunity in healthcare. Novo Nordisk and Eli Lilly dominate it today, but it may not be long before there's more competition.
3 Fantastic Growth Stocks to Buy in August
07:30am, Saturday, 17'th Aug 2024
Eli Lilly is a biopharma giant that could still deliver strong growth. Novo Nordisk's growth story isn't over thanks to Ozempic, Wegovy, and a promising pipeline.
Eli Lilly's Top GLP-1 Drugs Now Account for Nearly 40% of Its Revenue, and That's Likely to Go Higher in Future Quarters
07:21am, Saturday, 17'th Aug 2024
Eli Lilly's sales grew by 36% last quarter, largely due to the success of two products. The company has a promising molecule, tirzepatide, which has shown that it can help people lose significant weig
Lilly announces retirement of Marschall S. Runge from its Board of Directors
04:15pm, Friday, 16'th Aug 2024
INDIANAPOLIS , Aug. 16, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that Marschall S. Runge, M.D.
Why Lilly (LLY) Might be Well Poised for a Surge
01:21pm, Friday, 16'th Aug 2024
Lilly (LLY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
3 Companies Reporting Remarkable Results: WMT, LLY, CAH
11:16am, Friday, 16'th Aug 2024
The 2024 Q2 earnings season is slowly grinding to a halt, with the vast majority of S&P 500 companies already delivering quarterly results. Peeking a bit ahead, earnings for the current period (2024 Q
Lilly Completes Acquisition of Morphic to Improve Outcomes and Expand Options for People Living with Inflammatory Bowel Disease
08:38am, Friday, 16'th Aug 2024
Broadens Lilly's immunology pipeline with Morphic's oral integrin therapies, including MORF-057 Reinforces the company's strategy of delivering potential first or best-in-class therapies in the field
What Makes Eli Lilly (LLY) a Strong Momentum Stock: Buy Now?
01:02pm, Thursday, 15'th Aug 2024
Does Eli Lilly (LLY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Eli Lilly Stock A Buy Or A Sell After Mounjaro And Zepbound Crush Expectations?
12:45pm, Thursday, 15'th Aug 2024
Is Eli Lilly stock a buy or a sell after diabetes and obesity treatments easily beat second-quarter sales expectations?
